Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 214.50
Ask: 215.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.466%)
Open: 215.00
High: 217.00
Low: 213.00
Prev. Close: 215.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Fri, 13th Aug 2021 14:45

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Insig AI PLC - venture capital firm formerly known as Catena Group PLC - Matthew Farnum-Schneider resigns as executive chair, leaving after a short handover period, having served for two years. Richard Bernstein, "a long-term supporter and shareholder", is named interim non-executive chair until a permanent independent non-executive chair can be found. Bernstein, a 12.6% shareholder in Insig AI, was investment manager of AIM-listed Crystal Amber Fund Ltd.

----------

Palace Capital PLC - investor in regional UK commercial real estate - Stephen Silvester steps down as chief financial officer, leaving the board on October 29 after six years with Palace Capital. Head of Finance & Operations Matthew Simpson is promoted to finance director designate.

----------

US Solar Fund PLC - owns and operates solar power assets in North America - Notes that New Energy Solar Manager, the fund's manager, has promoted Liam Thomas to chief executive officer from chief investment officer. Thomas joined NESM in 2016 and has 17 years experience in the renewable energy, infrastructure, and agribusiness sectors, US Solar Fund says. Thomas replaces John Martin, who is leaving on September 30 to join renewable energy developer Windlab Pty Ltd.

----------

City Of London Investment Trust PLC - Hires Ominder Dhillon as a non-executive director, starting September 1. Dhillon was global head of Institutional Distribution at asset manager M&G PLC until the start of 2020. Prior M&G, he was head of Distribution at Impax Asset Management Group PLC.

----------

Keywords Studios PLC - Dublin-based technical services for video game developers - Hires Marion Sears and Neil Thompson as independent non-executive directors, starting immediately. Sears was a City analyst and investment banker. She currently is a non-executive director of retailer Dunelm Group PLC and senior independent director of Fidelity European Trust PLC and of Aberdeen New Dawn Investment Trust PLC. Thompson held senior positions at software firm Microsoft Corp and was part of the management team that launched Xbox into Europe, Keywords notes.

----------

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Hires Julie Krop as chief medical officer, joining from Nasdaq-listed Freeline Therapeutics Holdings PLC, where she held the same position.

----------

Prospex Energy PLC - investor in onshore and shallow offshore European gas and power projects - Receives letter from group of shareholders requisitioning a general meeting to remove existing and proposed directors and appoint new ones. Prospex says the documentation received doesn't form a valid request. Therefore, it won't call the meeting. However, the board has spoken to the shareholders and invited them to submit a valid request. Shareholders last month rejected the re-appointment of James Smith as a director, and the board currently has only three members.

----------

Trinity Exploration & Production PLC - oil assets in Trinidad and Tobago - Confirms Nicholas Clayton as permanent non-executive chair. Clayton had taken on the role on an interim basis following the death earlier this month of Bruce Dingwall, who had been executive chair. Managing Director Jeremy Bridglalsingh is promoted to CEO.

----------

Block Energy PLC - oil and gas development and production company focused on Georgia - Hires Jeremy Asher as non-executive director, effective immediately. Asher is chair & CEO of AIM-listed Tower Resources PLC. Block Energy shareholders at a general meeting on Wednesday had rejected proposals by Forest Nominees Ltd, acting on behalf of GP Jersey Ltd, to remove Chair Philip Dimmock and replace him with Charles Valceschini. Over 60% of votes were against both resolutions.

----------

Abcam PLC - Cambridge, England-based life science research tools - Hires Sally Crawford as non-executive director, starting immediately. Crawford was chief operating officer of US managed care firm Healthsource Inc and now is a health care consultant, based in New Hampshire.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2022 08:09

UPDATE: LONDON BRIEFING: Bank of England widens bond buying

(Alliance News) - The mood in global markets remained dark early Tuesday, with poor sessions in New York and Asia set to spill over to the European open.

Read more
11 Oct 2022 07:54

LONDON BRIEFING: Bank of England widens bond buying; UK jobless down

(Alliance News) - The mood in global markets remained dark early Tuesday, with poor sessions in New York and Asia set to spill over to the European open.

Read more
11 Oct 2022 07:05

Puretech, Nektar Therapeutics end merger talks

(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.

Read more
7 Oct 2022 09:51

TOP NEWS: PureTech Health in merger talks with Nektar Therapeutics

(Alliance News) - Clinical-stage biotherapeutics firm PureTech Health PLC on Friday confirmed it is in combination talks with San Francisco-based biopharmaceutical company Nektar Therapeutics Inc.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.